[18F]FDDNP performed better than [18F] Florbetapir to distinguish transthyretin cardiac amyloidosis (TTR-CA) patients from healthy controls: an ex vivo study

Detalles Bibliográficos
Autores principales: Dupont, Anne-Claire, Guilloteau, Denis, Ben-Azzouna, Rana, Bidault, Rudy, Algalarrondo, Vincent, Slama, Michel, Arlicot, Nicolas, Le Guludec, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642089/
http://dx.doi.org/10.1186/1750-1172-10-S1-P38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642089/
http://dx.doi.org/10.1186/1750-1172-10-S1-P38

Ejemplares similares